Dennis Langer - Aug 3, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Nathan A. Smith For: Dennis H. Langer
Stock symbol
MYGN
Transactions as of
Aug 3, 2021
Transactions value $
-$280,800
Form type
4
Date filed
8/5/2021, 05:11 PM
Previous filing
Jun 4, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $762K +30K +33.51% $25.39 120K Aug 3, 2021 Direct F1
transaction MYGN Common Stock Sale -$1.04M -30K -25.1% $34.75 89.5K Aug 3, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30K -100% $0.00* 0 Aug 3, 2021 Common Stock 30K $25.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to this option are fully vested and exercisable.